WELLS FARGO & COMPANY/MN - LOXO ONCOLOGY INC ownership

LOXO ONCOLOGY INC's ticker is LOXO and the CUSIP is 548862101. A total of 2 filers reported holding LOXO ONCOLOGY INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of LOXO ONCOLOGY INC
ValueSharesWeighting
Q4 2018$5,961,000
+67.0%
49,480
+51.7%
0.00%
+100.0%
Q3 2018$3,570,000
+32.4%
32,621
+22.2%
0.00%0.0%
Q2 2018$2,696,000
+23.8%
26,705
-31.4%
0.00%0.0%
Q1 2018$2,177,000
+57.0%
38,938
+1.1%
0.00%
Q4 2017$1,387,000
-16.5%
38,510
+113.6%
0.00%
-100.0%
Q3 2017$1,661,000
+28.7%
18,028
+12.0%
0.00%
Q2 2017$1,291,000
+97.7%
16,095
+3.8%
0.00%
Q1 2017$653,000
+75.1%
15,503
+33.3%
0.00%
Q4 2016$373,000
+116.9%
11,628
+76.6%
0.00%
Q3 2016$172,000
+57.8%
6,584
+39.8%
0.00%
Q2 2016$109,000
-18.0%
4,710
-3.6%
0.00%
Q1 2016$133,000
-0.7%
4,884
+3.0%
0.00%
Q4 2015$134,000
+644.4%
4,741
+359.4%
0.00%
Q3 2015$18,000
-28.0%
1,032
-25.8%
0.00%
Q2 2015$25,000
-10.7%
1,390
-40.7%
0.00%
Q1 2015$28,000
+1300.0%
2,344
+1295.2%
0.00%
Q4 2014$2,0001680.00%
Other shareholders
LOXO ONCOLOGY INC shareholders Q1 2019
NameSharesValueWeighting ↓
Aisling Capital LLC 4,028,920$129,409,00030.09%
Casdin Capital, LLC 360,000$11,561,0009.55%
DAFNA Capital Management LLC 139,722$4,487,0003.94%
Opaleye Management Inc. 125,000$4,014,0002.36%
Eventide Asset Management 740,000$23,765,0001.55%
Crawford Lake Capital Management, LLC 52,713$1,693,0001.22%
AWM Investment Company, Inc. 180,000$5,781,0001.13%
Orbimed Advisors 1,728,000$55,495,0000.71%
DRIEHAUS CAPITAL MANAGEMENT LLC 423,276$13,594,0000.48%
EAM Investors, LLC 111,268$3,573,0000.48%
View complete list of LOXO ONCOLOGY INC shareholders